EquityVest is thrilled to announce a successful funding round, having raised an impressive $2 million, which will significantly enhance our mission of connecting faith-driven entrepreneurs with investors who share their convictions. As a SEC-registered funding portal and a proud member of FINRA, EquityVest is dedicated to fostering a community that operates on the principles of faith, compassion, and entrepreneurship. Our platform stands out by helping companies that embody Christian values, enabling them to thrive while addressing critical social issues like poverty and promoting the gospel. The funds raised will be utilized to expand our platform, enhance our technical infrastructure, and develop educational resources designed to empower entrepreneurs in their journey. Through these endeavors, we aim to inspire a new wave of businesses that not only seek profit but also contribute to building a virtuous society. At EquityVest, we believe that by aligning financial investment with faith-based principles, we can catalyze transformative change that uplifts communities and creates sustainable growth. We are grateful for the support of our investors who share our vision and are excited about the opportunities this funding will enable. Together, we can cultivate a network of vibrant, values-centered businesses that not only succeed in the marketplace but also fulfill a higher calling in service to others. Stay tuned for more updates on our initiatives as we embark on this exciting journey!
Empowering Faith-Driven Entrepreneurship: EquityVest Announces Successful Funding Round
Get the full EquityVest company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
InflaRx
InflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation factor C5a and its receptor C5aR. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of inflammatory diseases. InflaRx’s lead product candidate, vilobelimab, is a novel, intravenously delivered, first-in-class, anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical studies in different indications. InflaRx is also developing INF904, an orally administered, small molecule inhibitor of the C5a receptor. InflaRx was founded in 2007, and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA. For further information, please visit www.inflarx.com
$150.0M Unknown
today
Lunar Outpost
Lunar Outpost is the industry leader in commercial space robotics, lunar surface mobility, and in-space infrastructure. We are on a mission to enable an extended human presence in space while utilizing the vast resources in space to drive positive impacts here on Earth. From our five rovers headed to the Moon to explore, prospect, and establish infrastructure, to the creation of oxygen on Mars, our impact spans the solar system. Lunar Outpost’s mobility and robotic systems, ranging from our exploration-class Mobile Autonomous Prospecting Platform (MAPP) rover to our truck-sized industrial Lunar Terrain Vehicle (LTV), will be the workforce for the New Space economy and enable Lunar Outpost to bring the infinite value of space to benefit humanity on Earth and beyond. Through notable commercialization and amazing partnerships, Lunar Outpost creates tremendous value in the New Space economy. Lunar Outpost leads the Lunar Dawn team, consisting of General Motors, Goodyear, and MDA Space – the leading consortium for LTV providing mobility for Artemis astronauts, a critical component of the broader Artemis campaign that will enable a sustainable presence on the Moon. Lunar Outpost’s five upcoming lunar surface missions will make history, with our first rover set to be the first commercial rover on the Moon and the first rover in history to explore the lunar South Pole, while enabling the first sale of space resources in human history alongside many other firsts. Each of our next four rover voyages build on our capabilities and technology, all leading towards mobility and robotic systems that can reliably operate in the most extreme environments our solar system has to offer.
$30.0M Series b
today
Darkhive
Darkhive develops US-produced open autonomous robotics systems for the defense and public safety communities.
$30.0M Series b
today
Founders First Capital Partners
National lender serving BIPOC, veteran, LGBTQ+, & women-owned businesses, as well as businesses in LMI zones & those committed to diverse hiring practices. Helping accelerate business growth through our Revenue-Based Funding products & Advisory Services. Together, we can create more jobs, increase your revenues and bottom line, and provide more growth capital to help your business. We’re backed by the nation’s top philanthropic organizations, so that we can fund you with the right capital.
$3.9M Unknown
today
Nelson
We help companies reduce their carbon footprints, control their mobility costs and use energy more efficiently. Our data-driven software enables companies to plan, deploy and operate a successful electrification strategy for their car fleet. Nelson combines companies' fleet data and the charging ecosystem data to provide personalized recommendations -in real time & automatically.
$3.5M Seed
today